What question did this study set out to answer?

The study aims to identify various forms of inhibin in postmenopausal women with ovarian cancers using different assays.

Inhibin forms in serum from postmenopausal women with ovarian cancers

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial identifies inhibin forms in ovarian cancers, highlighting diagnostic potential in postmenopausal women.

The study aims to identify various forms of inhibin in postmenopausal women with ovarian cancers using different assays.
Serum samples from 34 postmenopausal women with ovarian cancer were analyzed.
Inhibin levels were measured using inhibin B ELISA, Pro-alpha C subunit ELISA, RIA, and inhibin A ELISA.
Comparison of inhibin levels among different ovarian cancer types and non-cancer controls was conducted.
Granulosa cell tumours detected at 100% by RIA and inhibin B ELISA.
Mucinous tumours detected at 70% by RIA and 60% by inhibin B ELISA.
Serous tumours detected at 35% by RIA, while other assays showed lower detection rates.

Robertson et al. (1999) studied this question.

View Full Paper

Ask AI

Bookmark